6:01 PM
 | 
Feb 01, 2008
 |  BC Extra  |  Company News

FDA panel rebuffs Daiichi's Injectafer

FDA's Drug Safety and Risk Management Advisory Committee voted 14-2, with one abstention, that the data included in an NDA for IV Injectafer ferric carboxymaltose from Daiichi...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >